Genetic deletion as well as antibody-mediated inhibition of CD44 ameliorated obesity-related metabolic disorders in association with reduced WAT inflammation and hepatosteatosis despite the similar body weight in mice fed with HFD (28, 29). Here, CD44 is linked to Obesity.